03 October 2024

Bridge AI Conference 2024: Shaping the Future of AI Regulation in Portugal

The conference will present preliminary findings of the Bridge AI project, an ambitious initiative coordinated by INESC-ID, in collaboration with the Champalimaud Foundation and Unbabel. Leading academics, entrepreneurs, policymakers, and interested citizens will gather to discuss the implications and implementation of the European Union’s AI Act.

03 October 2024

Botton-Champalimaud Pancreatic Cancer Centre Operational from September 30

With fully functional inpatient and recovery units, as well as operating rooms, the Centre is now prepared to significantly expand the Champalimaud Foundation's capacity to treat pancreatic cancer patients. With a dedicated team of specialists in the treatment and research of this type of cancer, the Centre's mission is to deliver the highest standard of clinical care.

21 September 2024

New Therapies and Early Detection Discussed at the International Congress on Neurodegenerative Diseases

This congress reaffirmed the collaboration between the two countries in the research and treatment of neurodegenerative diseases such as Alzheimer's, a condition with a higher incidence in aging societies like those of Spain and Portugal, and with a profound economic and social impact.

11 September 2024

António Champalimaud Vision Award 2024 honours researchers who demonstrated how the brain recognises faces

The laureates of the 2024 António Champalimaud Vision Award are researchers Margaret Livingstone, Nancy Kanwisher, Doris Tsao (from the United States) and Winrich Freiwald (Germany) for their innovative contributions to understanding the neural mechanisms underlying facial recognition.  
 
The collective work carried out by these researchers has led to significant advances in the field of visual neuroscience, demonstrating how the brain processes and recognises faces, a fundamental aspect of social interaction and human cognition.
 

International Congress on Neurodegenerative Diseases

Co-organised by Fundación CIEN, Fundación Reina Sofía, and the Champalimaud Foundation, this scientific congress aims to bring advances in research in the fight against Alzheimer's and other neurodegenerative diseases to the public, and above all, to raise awareness to advance the search for global solutions and responses due to their social consequences.

16 July 2024

Claes Dohlman, "father" of modern corneal surgery and 2022 António Champalimaud Vision Award, has died

Claes Dohlman, emeritus professor of Ophthalmology and former chair of the Department of Ophthalmology at Mass Eye and Ear and Harvard Medical School, died on July 14, 2024. He was 101.

Often recognized as the “father” of modern corneal science, Dohlman shared the 2022 António Champalimaud Vision Award with Gerrit Melles, from the Netherlands Institute for Innovative Ocular Surgery in Rotterdam.

04 July 2024

Bridge AI: Spearheading Responsible AI in Portugal

Bridge AI is a collaborative effort involving the Champalimaud Foundation (CF), the Institute for Systems and Computer Engineering, Research and Development in Lisbon (INESC-ID), and Unbabel, among others. The initiative is part of the broader goal to align globally competitive AI innovation with European principles and values.

02 July 2024

What am I looking at? A Galactic Splatter

The images created during the daily scientific and medical endeavours at the Champalimaud Foundation can be as beautiful and compelling as any work of art. To the untrained eye, these images might also appear baffling, but, if you know what you’re looking at, they may just reveal information that can spark discoveries, contribute to the improvement of patient quality of life and maybe even alter our understanding of reality.

25 June 2024

What am I looking at? A Conundrum in Coral

The images created during the daily scientific and medical endeavours at the Champalimaud Foundation can be as beautiful and compelling as any work of art. To the untrained eye, these images might also appear baffling, but, if you know what you’re looking at, they may just reveal information that can spark discoveries, contribute to the improvement of patient quality of life and maybe even alter our understanding of reality.

20 June 2024

New CAML PhD Program in Surgical Oncology Research

This innovative programme is designed to develop future leaders in surgical oncology by combining cutting-edge scientific research with advanced surgical training. It offers a comprehensive and flexible doctoral curriculum for surgical residents, certified surgeons, and cancer-focused gastroenterologists and oncologists.

Subscribe to Champalimaud Foundation
Loading
Please wait...